Parallax Volatility Advisers
APTO

Parallax Volatility Advisers’s Aptose Biosciences, Inc. APTO Stock Holding History

Parallax Volatility Advisers’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-33
Closed -$64K – 3766
2020
Q4 		$64K Buy
+33
New +$77.5K ﹤0.01% 3021
2018
Q3 		– Sell
-3
Closed -$5K – 3826
2018
Q2 		$5K Hold
3
– – ﹤0.01% 1832
2018
Q1 		$4K Hold
3
– – ﹤0.01% 1969
2017
Q4 		$3K Hold
3
– – ﹤0.01% 3856
2017
Q3 		$2K Sell
3
-4
-57% -$2.69K ﹤0.01% 1964
2017
Q2 		$4K Sell
7
-7
-50% -$3.37K ﹤0.01% 2034
2017
Q1 		$6K Buy
+14
New +$7.17K ﹤0.01% 3282

Other funds holding APTO

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Parallax Volatility Advisers's APTO Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of Aptose Biosciences, Inc. (APTO) in Q1 2021, closing a stake of 33 shares — an estimated $64K sold.

Parallax Volatility Advisers first reported a position in APTO in Q1 2017 and held it in 7 quarters. The position peaked at $64K in Q4 2020. 70 funds tracked by Wall St. Rank hold APTO as of Q1 2021.

  • Parallax Volatility Advisers reported no remaining Aptose Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 33 Aptose Biosciences, Inc. shares in Q1 2021, an estimated $64K.
  • Parallax Volatility Advisers first reported a position in Aptose Biosciences, Inc. in Q1 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's Aptose Biosciences, Inc. position peaked at $64K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.